MARLBOROUGH, Mass., March 30, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in up-front cash. The […]
Financial
Arrhythmia Research Technology, Inc. Reports 2016 Fourth Quarter and Year End Results
FITCHBURG, Mass., March 22, 2017 (GLOBE NEWSWIRE) — Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary, Micron Products, Inc., a diversified contract manufacturing organization that produces highly-engineered, innovative medical device components requiring precision machining and injection […]
QT Vascular Scores $14.3 Million Capital
QT Vascular Secures Up To S$20 Million Capital Commitment GEM Global SINGAPORE, March 21, 2017 /PRNewswire/ — QT Vascular Ltd., (the “Company” or “QT Vascular“, and together with its subsidiaries, the “Group“) announced that it has signed an agreement (“Agreement“) with GEM Global […]
Bay Area’s Cardiva Med Banks $30 Million
Cardiva Medical Raises $30 Million – >Financing to Fuel Commercial Growth of VASCADE Vascular Closure System and Development of Next Generation Products for Vascular Closure SANTA CLARA, Calif., March 14, 2017 /PRNewswire/ — Cardiva Medical, an innovator in the field […]